() It is planned to spend 6.65 billion yuan to acquire the control right of Huitai Medical, and join forces to cultivate the country’s heavy weapon in the cardiovascular field.
On the evening of January 28th, Mindray Medical, a leading domestic medical device company, announced that it planned to acquire the control right of Huitai Medical, a listed medical device company in science and technology innovation board, by means of "agreement transfer+voting right" with its own funds of 6.65 billion yuan, so as to quickly lay out the subdivision track in cardiovascular field.
According to the acquisition plan, relevant entities such as the actual controller of Huitai Medical intend to transfer 14.12 million shares of Huitai Medical to Shenmai Control, a subsidiary of Mindray Medical, through agreement transfer, accounting for 21.12% of the company’s total share capital. At the same time, Cheng Zhenghui, the controlling shareholder and actual controller of Huitai Medical, will also give up the voting rights of the 10% shares still held.
At the same time as the transfer of this agreement, Shenzhen Maikong intends to acquire all 0.12% general partnership interests of Zhuhai Tongsheng held by Chenyi Hongqi (Mindray Medical holds 99.88% limited partnership interests of Zhuhai Tongsheng), and Zhuhai Tongsheng currently holds 3.49% shares of Huitai. In the end, if all the acquisition plans are successfully implemented, Mindray Medical will hold a total of 24.61% shares of Huitai Medical through its subsidiary Shenmai Control and its concerted action, Zhuhai Tongsheng, and become the largest shareholder of Huitai Medical.
6.65 billion yuan acquisition broke into the cardiovascular super track
For a long time, the field of medical devices has shown the industry characteristics of being strong and persistent. In addition, there are many subdivided tracks and the technology and channel synergy between tracks is limited. After the development of enterprises in the industry enters a certain stage, they all need to rely on extension mergers and acquisitions to cultivate new growth points and continue to expand their business boundaries, which is also true for Mindray Medical, the industry leader.
According to the data of comprehensive industry research report, the global market scale of cardiovascular field has reached 56 billion US dollars, and the market scale of China has also exceeded 50 billion RMB, ranking second in the global and domestic medical device market scale, second only to the field of in vitro diagnosis. In the context of the aging population, the market growth rate in cardiovascular field is significantly higher than that in other fields.
Mindray Medical hopes to quickly cut into the cardiovascular track under the tide of aging population by acquiring the controlling stake of Huitai Medical.
According to public information, as the acquired object, Huitai Medical has been focusing on the cardiovascular track for many years. In the domestic cardiovascular market monopolized by foreign brands, it has achieved a stable position in the segmentation fields such as cardiac electrophysiology, coronary artery access and peripheral vascular intervention, and mastered the full-line R&D and production capacity from upstream raw materials to products. It is a leading enterprise in the domestic cardiovascular field.
Among them, in the field of electrophysiology, the electrophysiology electrode catheter and controllable radiofrequency ablation catheter under Huitai Medical, as well as the floating temporary pacing electrode catheter approved for listing in 2020, are the first domestic products to obtain relevant registration certificates, and are recognized as national key new products by the Ministry of Science and Technology. In the field of vascular intervention, Huitai Medical has been involved in coronary artery access and peripheral vascular intervention, and a number of research and development products have filled the domestic clinical gaps.
Breakthrough innovative products have also brought rapid performance growth to Huitai Medical. In 2023, the company expects to achieve a net profit of 510-565 million yuan, a year-on-year increase of 42%-58%. The company’s value has also been recognized by market investors, and its share price has been stable above 300 yuan/share for a long time, ranking first in science and technology innovation board.
In order to get the leading position in this cardiovascular field, Mindray Medical has also made real money. It is understood that the comprehensive cost of this acquisition is about 450 yuan per share, which is about 25% higher than the latest closing price of Huitai Medical.
In this regard, Mindray Medical explained in the announcement that the starting point and timing of the acquisition of control rights are based on the company’s future strategic development direction and rhythm, aiming to help Mindray Medical quickly cut into the cardiovascular track by acquiring outstanding domestic companies and make positive contributions to Mindray’s long-term rapid growth.
Buying control rights at a premium is also a common operation in the capital market. Referring to the cases of transfer of control rights in Shanghai and Shenzhen Stock Exchanges since 2021, the average premium rate reached 29.58%, among which the average premium rate of medical-related cases reached 32.84%. In addition, in recent years, the average premium rate reached 34.43% in the cases of the transfer of control rights in the field of non-pharmaceutical medical care and health in overseas markets with a transaction scale of more than 500 million US dollars. In addition, from the perspective of Mindray Medical’s cash flow, as of the end of September 2023, the balance of the company’s monetary funds was 19.667 billion yuan, and the transaction amount was less than 1/3 of the book funds, which did not pose great pressure.
Extension acquisition gives birth to a new domestic leader.
In recent years, Mindray Medical has paid special attention to the driving effect of extended mergers and acquisitions on the company’s development. In 2021, the company acquired HyTest Bio, a world-renowned company in the field of IVD raw materials, and realized the independent control of core technologies in the field of IVD raw materials. In 2023, Mindray Medical once again completed the acquisition of DiaSys Holdings in Germany, and successfully built a global supply chain platform for in vitro diagnostic products, laying the foundation for the full internationalization of IVD business.
From the above acquisition cases, it can be found that Mindray Medical always hopes to go deep into the field and intensively cultivate new works with the role of industrial investment integrator, which will bring product R&D innovation and direct improvement of production and sales capabilities for both parties. The acquisition of Huitai Medical will also bring considerable market imagination to the two companies.
In the future, based on the rich experience of Mindray Medical and Huitai Medical in the field of medical equipment and consumables, a brand-new pattern of "Mindray Medical Equipment+Huitai Medical Consumables" is coming out. Mindray’s strong product engineering and system integration capabilities are also expected to further improve the performance of Huitai medical products. Based on Mindray Medical’s in-depth overseas market sales service system and different levels of customer resources, Huitai Medical’s cutting-edge innovative products can also be sold to a broader international market.
It can be said that the combined competitive advantage and cost-effective advantage brought by the combination of strong and powerful forces are becoming the direct weapon for the products of the two companies to break through the global market. The industrial integration with complementary resources is also expected to give birth to a new leader in the industry and open a new export market for domestic medical devices from the cardiovascular track.
(): In 2023, the cumulative sales volume of tap water was 236 million cubic meters, a year-on-year decrease of 2.71%.
Jiangnan Water Affairs announced the operating data. In 2023, the company accumulated 262 million cubic meters of tap water supply, a year-on-year decrease of 2.22%. The cumulative sales volume of tap water was 236 million cubic meters, a year-on-year decrease of 2.71%.
The controlling shareholder and actual controller of Youfa Group released the pledge of 121 million shares.
Youfa Group announced that on January 26 and 29, 2024, the company received notices from controlling shareholders and actual controllers Li Maojin, Chen Kechun and Liu Zhendong, and pledged its 121 million shares in Xinyin Wealth Management Co., Ltd. to be released. On January 26 and 29, 2024, both parties completed the procedures for releasing the above-mentioned restricted shares in China Securities Depository and Clearing Co., Ltd.
Huaibei Mining Industry: In 2023, the sales volume of commercial coal decreased by 5.27% year on year.
() Announcement, in 2023, the output of commercial coal was 21,973,400 tons, down 4.06% year-on-year; The sales volume of commercial coal was 17.832 million tons, down 5.27% year-on-year.
New Huangpu: Declare and issue public offering REITs for affordable rental housing.
() Announcement, the company intends to carry out the application and issuance of public offering of affordable rental housing-real estate investment trust fund in infrastructure field.
Weichuang Electric: It is planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone.
Weichuang Electric announced that the company signed the Investment Cooperation Agreement with the Changzhou Zhonglou Economic Development Zone Management Committee, and plans to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province, with a total planned investment of 500 million yuan.
New Huangpu: It is planned to declare and issue public offering REITs for affordable rental housing.
On the evening of January 29th, New Huangpu announced that in order to actively respond to the national housing policy of renting and selling at the same time, effectively revitalize the existing assets, form a virtuous circle of existing assets and new investment, and create important opportunities for promoting the rolling development of main business investment, the company plans to publicly raise the real estate investment trust funds (REITs) in the field of affordable rental housing-infrastructure (hereinafter referred to as "public REITs for affordable rental housing").
Weichuang Electric: It is planned to invest 500 million yuan to build a high-end electrical equipment production base project.
Weichuang Electric announced on the evening of January 29th that the company and Changzhou Zhonglou Economic Development Zone Management Committee signed the Investment Cooperation Agreement, and planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province. The total investment of the project is 500 million yuan, which is used to introduce high-voltage motors, transformers, water coolers, vibration platforms, incubators and other equipment, mainly engaged in high-voltage frequency converters, multi-transmission frequency converters and other businesses.
New Huangpu plans to declare and issue public offering REITs for affordable rental housing.
The new Huangpu announced that the company held the fourth meeting of the ninth board of directors on January 27, 2024, and reviewed and approved the Proposal on the Application and Issuance of Public Offering REITs for Affordable Rental Housing.
It is reported that the company intends to select the leased housing project of plot 02-03A-01a, Unit MHPO-0306, Meilong Town, Minhang District (referred to as "Meilong Community Project") as the underlying asset for the first time to declare and issue public offering REITs for affordable rental housing (the final specific project name is subject to the project declaration document). Meilong Community Project started construction in April 2020, obtained the certification of affordable rental housing in June 2021, completed the overall completion acceptance procedures in November 2022, and officially entered the market for supply in February 2023.
Warner Pharmaceutical Factory: Received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder (Ⅲ).
Warner Pharmaceutical Company announced on the evening of January 29th that it had received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder (III) approved and issued by National Medical Products Administration. Compound Polyethylene Glycol Electrolyte Powder (III) was used for colon cleaning preparation of patients before the following situations: endoscopy or radiological examination; Colon surgery.
Weichuang Electric plans to build a high-end electrical equipment production base project in Changzhou with a total investment of 500 million yuan.
Weichuang Electric announced that the company signed the Investment Cooperation Agreement with the Changzhou Zhonglou Economic Development Zone Management Committee, and planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province, and set up a subsidiary in Changzhou Zhonglou Economic Development Zone. The total investment of the project is 500 million yuan, which is used to introduce high-voltage motors, transformers, water coolers, vibration platforms, incubators and other equipment, mainly engaged in high-voltage frequency converters, multi-transmission frequency converters and other businesses.
Warner Pharmaceutical Factory: Received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder.
Warner Pharmaceutical Factory announced that it had received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder approved and issued by National Medical Products Administration, and the compound Polyethylene Glycol Electrolyte Powder was used for colon cleaning preparation of patients before the following situations: endoscopy or radiological examination; Colon surgery.
Warner Pharmaceutical Company obtained the registration certificate of compound polyethylene glycol electrolyte powder (Ⅲ).
Warner Pharmaceutical Company announced that it had received the Pharmaceutical Registration Certificate of Compound Polyethylene Glycol Electrolyte Powder (Ⅲ) approved and issued by National Medical Products Administration.
It is reported that compound polyethylene glycol electrolyte powder (ⅲ) is used for colon cleaning preparation of patients before the following situations: endoscopy or radiological examination; Colon surgery. This product is suitable for adults. Polyethylene glycol (4000) is a long-chain polymer, with which water molecules are bound by hydrogen bonds. After taking this medicine orally, the volume of intestinal fluid increased. These unabsorbed intestinal fluids make the medicine have catharsis characteristics.
Dayuan Pump Industry plans to transfer two cases of land use rights and related assets for 140 million yuan.
() Announced that the company intends to transfer two state-owned land use rights, buildings and other assets located in Danya Industrial Zone, zeguo town, Wenling City, Zhejiang Province to Zhejiang Lumei Pump Technology Co., Ltd. According to the assets appraisal report issued by Taizhou Xingyuan Assets Appraisal Co., Ltd. (Taixingping (2024) No.26) and through negotiation between both parties, the transaction price is determined to be RMB 140 million (including tax).
It is reported that according to the agreement, the relevant assets will be delivered in 2024. According to preliminary calculations, after the completion of this transaction, it is expected to increase the profit before corporate income tax in the current year by about RMB 50 million.
Dayuan Pump Industry: It is planned to sell some assets for 140 million yuan.
Dayuan Pump Industry announced on the evening of January 29th that it intends to transfer two state-owned land use rights, houses and buildings above the land to Zhejiang Lumei Pump Technology Co., Ltd. (hereinafter referred to as "Lumei Technology"). Through negotiation between both parties, it is determined that the transaction price is 140 million yuan (including tax), and the related assets will be delivered in 2024. After preliminary calculation, it is estimated that the profit before enterprise income tax will increase by about 50 million yuan in the current year.
Hengrui Pharma: The subsidiary product tacrolimus sustained-release capsules was approved by the US FDA.
() Announcement: Chengdu Sheng Di Pharmaceutical Co., Ltd., a subsidiary of the company, recently received a notice from the FDA that the company’s application for a simple new drug for tacrolimus sustained-release capsules (ANDA, American generic drug application) has been approved, which is the first generic drug approved by the FDA in the United States and the first generic product in China.
() A general meeting of shareholders will be held on February 27th to consider the proposal of electing Ms. Wang Yongting as a non-independent director of the eighth board of directors of the company.
Fuling Electric Power announced that the first extraordinary shareholders’ meeting will be held on February 27, 2024, and online voting will be conducted on the same day. Date of record is February 20th, and investors who hold shares of Fuling Power can vote after the market closes on that day.
Meeting place: Company meeting room at No.20 Wangzhou Road, Fuling District, Chongqing.
A total of 1 proposal was audited at this general meeting of shareholders, as follows:
1. Proposal on electing Ms. Wang Yongting as a non-independent director of the eighth board of directors of the company.
Hengrui Pharma: Tacrolimus sustained-release capsules were approved by FDA.
Hengrui Pharma announced that Chengdu Sheng Di Pharmaceutical Co., Ltd., a subsidiary of the company, received a notice from the US Food and Drug Administration (hereinafter referred to as "FDA") that the company’s application for a simple new drug for tacrolimus sustained-release capsules (ANDA, that is, the application for generic drugs in the United States) has been approved, which is the first generic drug approved by the US FDA and the first generic product in China.
In vivo and in vitro experiments have proved that tacrolimus is a powerful immunosuppressant, which can inhibit the production of cytotoxic lymphocytes, the activation of T cells, the proliferation of T helper cell-dependent B cells, the production of lymphatic factor (such as IL-2, IL-3 and IFN-γ) and the expression of IL-2 receptor.
The controlling shareholders of Guizhou Sanli and their concerted actions reduced their holdings by 2.9576%.
() Announcement was issued. As of the disclosure date of this announcement, the reduction period has expired, and the controlling shareholders and their concerted actions have reduced their holdings by a total of 12,122,300 shares, accounting for 2.9576% of the company’s total share capital.
Shanghai Wei, the major shareholder of Sanyou Medical, is reducing its shareholding by 1.35%.
Sanyou Medical announced that during the period from January 25th to January 29th, 2024, the shareholder of the company, Shanghai Zhengzheng Enterprise Management Partnership (Limited Partnership) ("Shanghai Zhengzheng"), reduced its shareholding by 3,344,600 shares, accounting for 1.35%, and its shareholding ratio decreased from 7.07% to 5.72%.
The approval of Goodwin’s fixed stock has expired.
Goodway announced that on February 13th, 2023, the company received the "Reply on Agreeing to the Registration of Goodway Technology Co., Ltd. to Issue Shares to Specific Objects" issued by China Securities Regulatory Commission (No.219, ZJK [2023]), and approved the company’s application for the registration of issuing shares to specific objects, with 12 replies from the date of agreeing to register (January 31st, 2023).
It is reported that the company has been actively promoting the issuance of this non-public offering of shares after obtaining the approval. However, due to various reasons such as changes in the capital market environment and the timing of issuance, the company failed to implement this non-public offering of shares within the validity period of the approval, and the approval will automatically expire.
Xuefeng Technology: 65.87 million restricted shares will be listed and circulated on February 5.
() Announced that the company’s stock listing type is non-public offering of shares. The total number of shares listed and circulated this time is 65.87 million shares, and the date of listing and circulation this time is February 5, 2024.
The total provision for impairment of proposed assets of Danhua Technology in 2023 is 98,774,200 yuan.
() Announcement, the company intends to make provision for impairment of assets with possible signs of impairment within the scope of consolidated statements as of December 31, 2023, totaling 98,774,200 yuan.
Sinopharm Modern: Lidocaine Hydrochloride Injection, a subsidiary, passed the consistency evaluation of generic drugs.
() Announcement: Shanghai Hyundai Hasen Pharmaceutical Co., Ltd., a holding subsidiary, received the Notice of Approval for Drug Supplement Application issued by National Medical Products Administration, and approved lidocaine hydrochloride injection to pass the consistency evaluation of generic drug quality and efficacy.
Sinopharm Modern: Lidocaine Hydrochloride Injection, a holding subsidiary, passed the conformity evaluation of generic drugs.
On January 29, Sinopharm Hyundai announced that the holding subsidiary lidocaine hydrochloride injection passed the consistency evaluation of generic drugs; The holding subsidiary obtained the registration certificate of ambroxol hydrochloride oral solution drug.
Lianhuan Pharmaceutical received the results of GMP compliance inspection.
() Announcement: The company learned from the website of Jiangsu Provincial Drug Administration that the Notice of GMP Compliance Inspection Results, and conducted good manufacturing practice compliance inspection and evaluation on Jiangsu Lianhuan Pharmaceutical Co., Ltd. according to the relevant provisions of the Drug Administration Law and the Measures for the Supervision and Administration of Drug Production, and the results met the requirements.
This is the first time that Fluhydrocortisone Acetate has passed the GMP compliance inspection. The GMP compliance inspection of Troxerutin and Terfenadine Granules is the certification of resumed production varieties after the change of production site, and they are all collinear with other varieties, and no new investment has occurred.
Kang Enbei: Repurchase 5,471,800 shares of the company for the first time by centralized bidding transaction.
On January 29th, () announced that the company repurchased 5,471,800 A shares of the company through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 0.21% of the company’s total share capital of 2,570 million shares. The highest price of the repurchase transaction was RMB 4.7 yuan/share, and the lowest price was RMB 4.57/share. The total amount of funds paid was RMB 25,265,300 (excluding stamp duty, trading commission and other transactions)
According to the previously disclosed Proposal on Repurchase of Company’s Shares by Centralized Bidding, the company intends to use its own funds to repurchase the company’s shares by centralized bidding through the trading system of Shanghai Stock Exchange for the implementation of equity incentives. The total amount of funds to be repurchased is not less than RMB 200 million (inclusive) and not more than RMB 400 million (inclusive); The price of repurchased shares shall not exceed RMB 7 yuan/share (inclusive).
(Shanghai Stock Exchange)
Juhua Co., Ltd.: The refrigerant revenue in 2023 was 5.807 billion yuan, a year-on-year decrease of 15.05%.
() Announced the main operating data from January to December, 2023. The revenue of the company’s main product fluorine chemical raw materials was 1.05 billion yuan, a year-on-year decrease of 20.47%; Refrigerant revenue was 5.807 billion yuan, a year-on-year decrease of 15.05%.
Mindray Medical intends to be the main enterprise in the field of electrophysiology, Huitai Medical.
Mindray Medical announced on the evening of January 28th that the company intends to acquire 14.12 million ordinary shares of Huitai Medical held by Cheng Zhenghui, Cheng Ling, Dai Zhenhua and other transferors by means of agreement transfer, accounting for 21.12% of the total share capital of the target company, with a total transfer amount of RMB 6.652 billion.
The main business of Huitai Medical is the research and development, production and sales of products such as electrophysiology, coronary artery access and peripheral vascular intervention.
At the same time, Cheng Zhenghui, the actual controller of Huitai Medical, promised to voluntarily, permanently and irrevocably give up the voting rights of 10% of the shares of the target company from the date when he received all the share transfer price according to the agreement.
In addition, Shenmai Control also intends to acquire all 0.12% general partnership interests of Zhuhai Tongsheng Investment Partnership (Limited Partnership) held by Chenyi Hongqi (Beijing) Consulting Co., Ltd. (hereinafter referred to as "Zhuhai Tongsheng"), and Zhuhai Tongsheng currently holds 3.49% shares of Huitai Medical.
After the completion of the above three transactions, Shenmaikong will directly hold 14.12 million shares of Huitai Medical, accounting for 21.12% of the total share capital of Huitai Medical; Zhuhai Tongsheng, the concerted action person of Shenzhen Maikong, directly holds 2,335,300 shares of Huitai Medical, accounting for 3.49% of the total share capital of Huitai Medical. Shenzhen Maikong and its concerted action person Zhuhai Tongsheng hold 16,455,600 shares of Huitai Medical, accounting for 24.61% of the total share capital of Huitai Medical. The controlling shareholder of Huitai Medical will be changed to Shenzhen Maikong, and the actual controllers will be changed to Li Xiting and Xu Hang.
The proportion of UFIDA network repurchase reached 1.01%, costing 666 million yuan.
() Announcement: As of January 29, 2024, the company has repurchased 34,654,400 shares, accounting for 1.0137% of the company’s current total share capital, an increase of 0.1202% compared with the last disclosure. The highest purchase price is 23.39 yuan/share, the lowest purchase price is 12.35 yuan/share, and the total amount paid is 666 million yuan (no
Anfu Technology: Shareholders intend to reduce their shares by no more than 1%.
() On the evening of January 29th, it was announced that Zhang Jinghong, a shareholder holding 5.77% of the shares, planned to reduce his shareholding by no more than 1%.
TBEA: The holding company plans to invest in the construction of Xi ‘an digital factory project.
On January 29th, () announced that the holding company TBEA Xi ‘an Electric Technology Co., Ltd. planned to invest in the construction of Xi ‘an digital factory project with a total investment of 1.16 billion yuan.
The Asian strategy of Goldman Sachs, the shareholder of Xianheng International, has reduced its holdings by 1.99% and reduced its holdings by more than half.
() Announcement was issued. On January 29, 2024, the company received the Letter of Notice on the Progress of Share Reduction issued by Goldman Sachs Asia Strategic Pte. Ltd. (hereinafter referred to as "Goldman Sachs Asia Strategy"). As of January 29, 2024, Goldman Sachs Asia Strategy had reduced its shareholding by 8.195 million shares, accounting for 1.99% of the company’s total share capital, without centralized bidding. The number of this reduction plan has exceeded half, and the implementation of this reduction plan has not yet been completed.
Longji Green Energy: It is planned to implement the first increase on January 30, 2024.
() Announcement, the company received a notice from the chairman, Mr. Zhong Baoshen, that it intends to implement its first increase on January 30, 2024, and will continue to implement its increase plan in the future.
Longji Green Energy: Zhong Baoshen, Chairman of the Board of Directors, plans to implement the first increase on January 30, 2024.
Longji Green Energy announced that it was previously disclosed that Chairman Zhong Baoshen plans to increase the company’s shares in a way allowed by the Shanghai Stock Exchange system within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Chairman Zhong Baoshen that it planned to implement its first increase on January 30, 2024, and will continue to implement its increase plan.
Langfang development: Evergrande Real Estate’s shares in the company have been waiting for freezing, accounting for 20% of the company’s total share capital.
() Announcement: As of the date of this announcement, Evergrande Real Estate holds 76,032,050 shares, accounting for 20% of the company’s total share capital. After the shares were frozen, the cumulative number of shares held by Evergrande Real Estate was 76,032,050, accounting for 100% of the total shares held by Evergrande and 20% of the total share capital of Evergrande.
Longji Green Energy: The chairman of the board plans to implement the first increase on January 30, 2024.
Longji Green Energy announced on the evening of January 29th that Chairman Zhong Baoshen plans to increase the company’s shares within 12 months from October 31st, 2023 through the way permitted by the Shanghai Stock Exchange system, and the amount of increase is not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to implement its first increase on January 30, 2024, and will continue to implement its increase plan.
() A shareholders’ meeting will be held on February 19th to consider the proposal on the settlement of the initial public offering of shares and the permanent replenishment of working capital with the remaining raised funds.
Guansheng shares announced that the second extraordinary general meeting of shareholders will be held on February 19, 2024, and online voting will be held on the same day. Date of record falls on February 6th, and investors who hold Guansheng shares after the market closes on that day can vote.
Venue: No.1 Gaoxiang Road, Ouhai High-tech Industrial Park, Wenzhou City, Zhejiang Province.
A total of 1 proposal was audited at this general meeting of shareholders, as follows:
1. Proposal on the Settlement of the Initial Public Offering of Shares and the Permanent Supplement of the Funds Raised from the Savings to the Working Capital.
Top Group will hold a shareholders’ meeting on February 19th to consider two proposals.
() Announce that the first extraordinary general meeting of shareholders will be held on February 19, 2024, and online voting will be conducted on the same day. Date of record is February 6th, and investors who hold shares of Top Group can vote after the market closes on that day.
Venue: Meeting Room C-105, Company Headquarters, No.268 Yuwangshan Road, Beilun District, Ningbo.
A total of two proposals were audited at this general meeting of shareholders, as follows:
1. Proposal on increasing the amount of entrusted financing for idle raised funds.
2. Proposal on adding idle raised funds to supplement the liquidity line.
() The net profit for 2023 was reduced by 320 million to 420 million yuan, which plummeted by 69% to 77% year-on-year.
Weiwei Gaoxin disclosed the announcement of pre-reduction of annual results in 2023. The company expects the net profit attributable to shareholders of listed companies to be 320 million yuan to 420 million yuan during the reporting period, down 76.63% to 69.33% year-on-year. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 200 million yuan to 300 million yuan, down 85.41% to 78.12% year-on-year.
During the reporting period, the competition in the polyvinyl alcohol (PVA) industry intensified, and the market changed greatly. The domestic and foreign trade market prices of the main products, vinyl acetate and polyvinyl alcohol, fell by about 40%, and the market prices of other products also fell to varying degrees, narrowing the profit margin.
Consistency evaluation of Sinopharm Hasen drugs, a subsidiary of Sinopharm Modern Holdings, passing generic drugs.
Sinopharm Hyundai announced that Shanghai Hyundai Hasen (Shangqiu) Pharmaceutical Co., Ltd. (hereinafter referred to as Sinopharm Hasen), a holding subsidiary of the company, received the Notice of Approval for Drug Supplement Application approved by National Medical Products Administration, and approved lidocaine hydrochloride injection (5ml：0.1g) to pass the consistency evaluation of generic drug quality and efficacy.
It is reported that lidocaine hydrochloride injection is a local anesthetic and antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. Can be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, and can also be used for digitalis poisoning, cardiac surgery and ventricular arrhythmia caused by cardiac catheter.
Langfang development: Evergrande Real Estate’s shares in the company have been waiting for freezing, accounting for 20% of the total share capital.
Langfang Development Announcement: As of the date of this announcement, Evergrande Real Estate holds 76,032,050 shares, accounting for 20% of the company’s total share capital. After the shares were frozen, the cumulative number of shares held by Evergrande Real Estate was 76,032,050, accounting for 100% of the total shares held by Evergrande and 20% of the total share capital of Evergrande.
On January 29th, 2024, the company received the Notice of Judicial Freeze and Judicial Transfer of Equity from China Securities Depository and Clearing Co., Ltd. Shanghai Branch (No.0129-1 in 2024) and the Notice of Assistance in Execution from Lianyungang Intermediate People’s Court [(2023) Su 07 Zhi No.285]. Due to the dispute over the loan contract between Lianyungang Cangwu Sub-branch of Agricultural Bank of China Co., Ltd. and Evergrande Real Estate Group Co., Ltd., the ruling of (2023) Su 07 Zhi No.285 made by Lianyungang Intermediate People’s Court of Jiangsu Province has taken legal effect, and 76,032,050 shares of the company held by Evergrande Real Estate are waiting to be frozen.
Dayuan Pump Industry: It is planned to sell some assets for 140 million yuan.
On the evening of January 29th, Dayuan Pump Industry announced that it planned to sell two state-owned land use rights, houses and buildings above the land in Danya Industrial Zone, zeguo town, Wenling City, Zhejiang Province to Zhejiang Lvmei Pump Technology Co., Ltd., with a total transaction price of 140 million yuan (including tax). Both parties to the transaction refer to the evaluation results and determine the transaction price through consultation. After the transaction is completed, it is estimated that the profit before enterprise income tax in the current year will be increased by about 50 million yuan, which will have a positive impact on the company’s profit in the relevant reporting period.
Weichuang Electric: Signed Investment Cooperation Agreement with Changzhou Zhonglou Economic Development Zone Management Committee.
On the evening of January 29th, Weichuang Electric announced that the company had signed the Investment Cooperation Agreement with the Changzhou Zhonglou Economic Development Zone Management Committee, and planned to build a high-end electrical equipment production base project in Changzhou Zhonglou Economic Development Zone, Jiangsu Province. The total planned investment of the project is 500 million yuan (subject to the actual investment in the end).
Haili Bio: Jiemen Bio, a wholly-owned subsidiary, obtained the invention patent certificate.
On the evening of January 29th, () announced that Shanghai Jiemen Biotechnology Co., Ltd. (hereinafter referred to as "Jiemen Biotechnology"), a wholly-owned subsidiary of the company, had recently received the invention patent certificate issued by China National Intellectual Property Administration, with the invention name: a serum-free medium suitable for the adherent growth of hybridoma cells. The acquisition of the above invention patents is the embodiment and extension of the important core technology of Jiemen Bio.
Antu Bio: It is planned to buy back shares at a price of 250-500 million yuan.
On January 29th, () announced that it planned to buy back shares at a price of 250-500 million yuan, cancel all of them and reduce the registered capital of the company. The repurchase price shall not exceed 60 yuan/share.
Longji Green Energy: Chairman Zhong Baoshen plans to increase his holdings for the first time on January 30th.
Longji Green Energy announced that the company received a notice from Chairman Zhong Baoshen that it plans to implement its first increase on January 30, 2024, and will continue to implement its increase plan. Longji Green Energy has previously disclosed that Chairman Zhong Baoshen plans to increase the company’s shares within 12 months from October 31, 2023, with an increase of not less than 100 million yuan.
Dayuan Pump Industry: The assets to be sold will increase the profit before enterprise income tax by about 50 million yuan.
Dayuan Pump Industry announced that the company intends to transfer two state-owned land use rights, buildings and other assets located in Danya Industrial Zone, zeguo town, Wenling City, Zhejiang Province to Zhejiang Lumei Pump Industry Technology Co., Ltd. The transaction price is 140 million yuan (including tax). According to preliminary calculation, after the completion of this transaction, it is expected that the profit before enterprise income tax will increase by about 50 million yuan in the current year.
Baosteel packaging: It is planned to buy back shares at a price of RMB 50 million to RMB 100 million.
() On the evening of January 29th, it was announced that it was planned to buy back shares at a price of 50 million yuan to 100 million yuan, and the upper limit of the repurchase price was planned to be no more than 7.66 yuan/share. This share repurchase is intended to be used for the continuous implementation of the equity incentive plan in the future.
Antu Bio: It is planned to buy back shares at a price of 250 million yuan-500 million yuan.
Antu Bio announced on the evening of January 29th that it plans to buy back its shares at a price of 250-500 million yuan, with the repurchase price not exceeding 60 yuan/share. All the repurchased shares will be cancelled and the registered capital of the company will be reduced.
Tang Yu Investment, shareholder of Alice, completed the reduction of 2.34% shares.
Alice announced that Jiaxing Tangyu Investment Partnership (Limited Partnership) (hereinafter referred to as "Tangyu Investment"), a shareholder of the company, has reduced its shareholding by 10,514,700 shares through centralized bidding and block trading, accounting for 2.34% of the company’s total share capital. The planned time interval for this reduction has expired.
Baosteel packaging: It is planned to buy back shares from 50 million yuan to 100 million yuan.
Baosteel packaging announced that it plans to buy back shares at a price of 50 million yuan to 100 million yuan for the continuous implementation of the equity incentive plan in the future, with the repurchase price not exceeding 7.66 yuan per share.
Yifeng Pharmacy: Vice President Tian Wei resigned for personal reasons.
On January 29th, () announced that the board of directors of the company recently received a written resignation report submitted by Tian Wei, vice president of the company, and Tian Wei applied to resign as vice president of the company for personal reasons. According to relevant regulations, Tian Wei’s application for resignation will take effect from the date when it is delivered to the board of directors of the company. After Tian Wei resigned as vice president, he will no longer hold other positions in the company.
(Shanghai Stock Exchange)
42,455,800 restricted shares of Secco Sid will be listed and circulated on February 6th.
Secco Sid announced that the company’s total number of shares listed and circulated this time was 42,455,800 shares, and the listing date was February 6, 2024.
By the end of the fourth quarter, the contracted construction area of Zhujiang shares was 38.1402 million square meters.
() Announced that by the end of the fourth quarter of 2023, the company (including Guangzhou Pearl River Urban Management Service Group Co., Ltd. and Guangzhou Pearl River Sports and Culture Development Co., Ltd.) was in charge of 371 residential, public and stadium projects, with a total contracted construction area of about 38.1402 million square meters. Among them, there are 148 residential projects with a construction area of about 19,368,500 square meters; 198 public construction projects with a construction area of about 15,688,800 square meters; There are 25 sports venues with a construction area of about 3,082,800 square meters, including 20 large-scale sports venues with a construction area of about 2,625,100 square meters.
The controlling shareholder of Xiamen Xiangyu completed the increase of 1.01% of its shares.
() Announcement: From October 31, 2023 to January 29, 2024, Xiamen Xiangyu Group Co., Ltd. (referred to as "Xiangyu Group"), the controlling shareholder of the company, increased its holdings of 22,901,100 shares by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for 1.01% of the company’s issued shares, with a cumulative increase of 150 million yuan. This increase plan was completed.
Antu Bio will hold a shareholders’ meeting on February 20th to consider the proposal of repurchasing the company’s shares by centralized bidding.
Antu Bio announced that the first extraordinary general meeting of shareholders will be held on February 20, 2024, and online voting will be held on the same day. Date of record is February 2nd, and investors who hold Antu Bio shares can vote after the market closes on that day.
Meeting place: company meeting room.
A total of 1 proposal was audited at this general meeting of shareholders, as follows:
1. Proposal on the plan of repurchasing the company’s shares by centralized bidding transaction.
() A general meeting of shareholders will be held on February 20th to review the proposal on the company’s 2024 annual guarantee amount.
Yijing Optoelectronics announced that the first extraordinary general meeting of shareholders will be held on February 20, 2024, and online voting will be held on the same day. Date of record is February 6th, and investors who hold Yijing Optoelectronic shares after the market closes on that day can vote.
Meeting place: meeting room on the 8th floor of Changzhou Yijing Optoelectronic Technology Co., Ltd. (No.18 Jinwu Road, Jintan District, Changzhou City, Jiangsu Province).
A total of 1 proposal was audited at this general meeting of shareholders, as follows:
1. Proposal on Estimated Guarantee Amount of the Company in 2024.
(): Sign a long-term loan agreement with IFC, the international finance company, with the maximum amount not exceeding USD 100 million equivalent to RMB.
On January 29th, Health Yuan announced that the company signed the Loan Agreement between Health Yuan Pharmaceutical Group Co., Ltd. and International Finance Corporation with International Finance Corporation (IFC) on the same day, and the company intends to apply to IFC for a long-term loan with the maximum principal amount not exceeding USD 100 million equivalent and the final repayment date not later than May 15th, 2032. The loan interest rate is no more than 1.0% on the basis of the RMB Fixed Base Rate determined at the time of lending. The loan is mainly used for the company to build production and R&D facilities in Henan and Guangdong, and other investments related to key treatment fields, including working capital requirements.
The announcement shows that the company’s application for long-term loans from IFC can effectively meet the company’s future business development needs, effectively expand the company’s diversified financing channels, reduce financing costs, and provide good financing support for the company’s sustained, stable and healthy development.
(Shanghai Stock Exchange)
Baiaotai: It is estimated that the net loss in 2023 will be 350-450 million yuan, a year-on-year decrease, and the sales in adalimumab will increase year-on-year.
On January 29th, Baiaotai announced that the company expected a net loss of 350-450 million yuan in 2023, compared with a net loss of 480 million yuan in the same period last year, a year-on-year decrease.
In 2023, the company’s operating income is expected to increase by 200 million yuan to 300 million yuan compared with the same period of last year. The main reason is that the company actively expands the market, and the sales of Geluoli (adalimumab) injection has steadily increased compared with the same period of last year; Second, the company’s drug Shireili (Tozumab) injection received the Drug Registration Certificate issued by National Medical Products Administration in January 2023, and the drug sales revenue increased; Third, with the increase in the sales of Bevacizumab injection, the revenue from drug sales commission and sales milestone increased.
During the reporting period, the R&D expenditure is expected to increase by 100 million yuan to 200 million yuan compared with the same period of last year. On the one hand, the company adheres to the innovation-driven development strategy, attaches great importance to drug research and development, and continuously enriches the R&D pipeline, and the R&D investment increases during the reporting period; On the other hand, many projects of the company are in clinical phase III, and the clinical trial fees and technical service fees increase, resulting in an increase in research and development expenses.
(Shanghai Stock Exchange)
In the fourth quarter, Space-Time Technology signed a new contract worth 163 million yuan.
() Announcement: From October to December in 2023, the company signed 12 new projects, with a new contract amount of 163 million yuan.
Zhang Jinghong, a shareholder of Anfu Technology, intends to reduce his shareholding by no more than 1%.
Anfu Technology announced that according to the market price, Zhang Jinghong, a shareholder of the company, intends to reduce the number of shares of the company by no more than 1.456 million shares (that is, no more than 1% of the total number of shares of the company) within 90 days after 15 trading days from the date of disclosure of this announcement.
(): It is estimated that in 2023, the company will make provision for depreciation of cobalt-related inventories of about 43 million yuan.
Pengxin Resources announced that it is estimated that in 2023, the company will make provision for depreciation of cobalt-related inventories of about 43 million yuan. At the same time, the company’s Congo (DRC) cathode copper production line was overhauled and debugged, and local power cuts and other factors affected the production and sales of cathode copper. In addition, West Gold Plant (Pty) Ltd., which was newly incorporated into the scope of merger, lost about 31 million yuan. The above forecast data are only preliminary accounting data, and the specific and accurate financial data are subject to the audited 2023 annual report officially disclosed by the company.
Japanese fashion executives receive warning letters because of spouse’s short-term transaction.
On January 29th, 2024, Shanghai Supervision Bureau of China Securities Regulatory Commission announced that Zhang Yunju, a senior manager of () Group (hereinafter referred to as Nikko Fashion) (chief financial officer and secretary of the board of directors), was suspected of illegal operation, and his spouse Zhang Qingdong had bought 62,200 shares of Nikko Fashion from September 6th, 2023 to October 10th, 2023, with a total amount of 1,064,576. Selling 47,200 shares of the company, with a total amount of 805,565.00 yuan, and holding 15,000 shares as of January 10, 2024, constitutes a short-term trading behavior. In order to maintain market order and regulate illegal trading, according to the relevant provisions of the Securities Law of People’s Republic of China (PRC), Zhang Yunju was taken to issue a warning letter.
Pacific Securities: Shareholder Jiayu Investment lifted the waiting freeze on the shares of the company.
Pacific Securities announced this evening that the company recently received the Notice of Judicial Freeze and Judicial Transfer of Equity issued by China Securities Depository and Clearing Co., Ltd. Shanghai Branch and the Notice of Assistance in Execution issued by the Haidian District People’s Court in Beijing, and learned that all the shares of the company held by Jiayu Investment were released from the waiting freeze.
As of the disclosure date of the announcement, Beijing Jiayu Investment Co., Ltd. ("Jiayu Investment") holds 744 million shares of Pacific Securities, accounting for 10.92% of the company’s total share capital. This time, 744 million shares were released from the waiting list, accounting for 100% of its shares.
Pacific Securities said that the lifting of the waiting freeze of Jiayu Investment shares did not have a substantial impact on the company’s operation and corporate governance.
Kang Enbei: Repurchase 5,471,800 shares for the first time.
On the evening of January 29th, Kang Enbei announced that on January 29th, 2024, the company repurchased 5,471,800 shares of A shares of the company through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 0.21% of the company’s total share capital of 257,037,319 shares. The highest price of the repurchase transaction was 4.7 yuan/share, the lowest price was 4.57 yuan/share, and the total amount of funds paid was 2,526.
UFIDA: Accumulated repurchased 34,654,423 shares.
On the evening of January 29th, UFIDA announced that as of January 29th, 2024, the company repurchased 4,111,300 shares in January through centralized bidding, and the cumulative number of repurchased shares was 34,654,423 shares, accounting for 1.0137% of the company’s current total share capital, an increase of 0.1202% compared with the last disclosure, and the highest purchase price was 23.39 yuan/share.
State Grid Yingda: The company plans to make provision for impairment of 273 million yuan.
() According to the announcement, the company held the 12th meeting of the 8th Board of Directors and the 8th meeting of the 8th Board of Supervisors today, and reviewed and approved the Proposal on Provision for Impairment in 2023. In 2023, the company plans to make provision for impairment of 273 million yuan, reducing the profit of consolidated statements in 2023 by 273 million yuan. The financial data related to the provision for impairment has not been audited, and the final accounting treatment is subject to the results confirmed by the annual audit.
Goodway: The approval for issuing shares to a specific object expires.
Goodway announced that on February 13th, 2023, the company received a reply from China Securities Regulatory Commission, agreeing to the company’s application for registration of issuing shares to a specific target, and the reply will be valid for 12 months from the date of consent to registration (January 31st, 2023). Due to various reasons such as changes in the capital market environment and the timing of issuance, the company failed to implement this non-public offering of shares within the validity period of the approval, and the approval automatically became invalid when it expired.
Guobo Electronics: Shareholders promise not to reduce their shares in the company in the next six months.
Guobo Electronics announced on the evening of January 29th that its shareholder, CLP Guowei (Tianjin) Integrated Circuit Chip Partnership (Limited Partnership), voluntarily promised not to reduce its shares in the company in any way in the next six months (January 29th to July 28th) from January 29th.
Xiao Zhihua, the controlling shareholder of Opmai, completed the increase of 120,600 shares.
Opmai announced that Xiao Zhihua, the controlling shareholder, chairman and general manager of the company, increased his holdings of 120,600 shares by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for about 0.1051% of the total issued share capital of the company, and this increase plan has been implemented.
Xiangyu, Xiamen: The holding plan of Xiangyu Group, the controlling shareholder, has been implemented.
On the evening of January 29th, Xiamen Xiangyu announced that, according to the notice of Xiamen Xiangyu Group Co., Ltd. (hereinafter referred to as "Xiangyu Group"), the controlling shareholder of the company, from October 31st, 2023 to January 29th, 2024, Xiangyu Group increased its holdings of 22,901,069 shares of the company by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for 1% of the company’s issued shares.
Yingliu Co., Ltd. plans to set up a joint venture company to engage in the business of fusion reactor materials and components.
() Announcement was issued. On January 29th, 2024, the company signed the Sponsor Agreement on the Establishment of Anhui Juneng New Materials Technology Co., Ltd. with Hefei Energy Research Institute Co., Ltd. of Comprehensive Science Center and natural persons Yao Damao, Qi Qiang and Liu Songlin, and planned to jointly contribute to the establishment of a joint venture company to engage in the development, production and sales of fusion reactor materials and components and nuclear detection instruments. The registered capital of the joint venture company is RMB 50 million, of which Yingliu shares intend to contribute RMB 30 million in cash and in kind, making it the largest shareholder of the joint venture company.
According to the company, Anhui Juneng New Materials Technology Co., Ltd. was established by the company’s foreign investment this time, with the purpose of rapidly starting the transformation of manufacturing technology of high-heat load components of nuclear fusion devices and technical achievements of shielding materials, and laying a foundation for the company’s long-term development in line with major national strategies in the field of energy equipment.
All shares of the company held by Jiayu Investment, a shareholder of Pacific Securities, were released from the waiting freeze.
On the evening of January 29th, Pacific Securities announced that the company had recently learned that all the shares of the company held by Beijing Jiayu Investment Co., Ltd. (hereinafter referred to as "Jiayu Investment") had been lifted from the waiting freeze.
According to the announcement, Jiayu Investment was sued by Hubei Hump Investment Co., Ltd. to the Haidian District People’s Court in Beijing due to private lending disputes, and all the shares of Pacific Securities held by Jiayu Investment were waiting to be frozen. As of the announcement date, Jiayu Investment holds 744 million shares of Pacific Securities, accounting for 10.92% of the company’s total share capital. This time, the waiting list of frozen shares was lifted by 744 million shares, accounting for 100% of its shares.
TBEA: The holding company plans to invest 1.163 billion yuan in Xi ‘an digital factory project.
TBEA announced that in order to seize the "double-carbon" market opportunity, expand the production capacity of the company’s inverter and other power electronic products, and improve the company’s competitiveness and profitability in the new energy power electronic equipment market, TBEA Xi ‘an Electric Technology Co., Ltd. ("Xike Company"), the company’s holding company, invested in the construction project of 5G digital factory and science and technology R&D building in Xi ‘an Industrial Park ("Xi ‘an Digital Factory Project"), with a total investment of 1.163 billion yuan and a construction period of 24 months.
Zhong Baoshen, chairman of Longji Green Energy, plans to increase its holdings for the first time on January 30.
Longji Green Energy announced that Zhong Baoshen, the chairman of the company, plans to increase the company’s shares in a way allowed by the Shanghai Stock Exchange system within 12 months from October 31, 2023, with an increase of not less than RMB 100 million and not more than RMB 150 million. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to implement its first increase on January 30, 2024, and will continue to implement its increase plan.
Lexin Technology: It is planned to buy back the company’s shares at a price of 50 million-100 million yuan.
Lexin Technology announced on the evening of January 29th that it plans to buy back the company’s shares at a price of 50-100 million yuan, with the repurchase price not exceeding 120 yuan/share. The repurchased shares will be used for employee stock ownership or equity incentive plan.
Shaanxi Construction Co., Ltd.: The management adjusted Chen Qi to be the chairman.
On the evening of January 29th, () announced that Chen Qi, general manager of Shaanxi Construction Holding Group, was appointed as the chairman of Shaanxi Construction Co., Ltd.. Gao Jiancheng and Yang Haisheng, deputy general managers of Shaanxi Construction Holding Group, are directors of Shaanxi Construction Co., Ltd..
It is also known that Zhang Yiguang, the former chairman of Shaanxi Construction Co., Ltd., has served as a counselor of the Shaanxi Provincial Government; Mao Jidong, former vice chairman of Shaanxi Construction Co., Ltd., has served as Party Secretary and Chairman of Shaanxi Construction Holding Group; Mo Yong, the former director and general manager of Shaanxi Construction Co., Ltd., has been transferred to the general manager of Shaanxi Nonferrous Metals Group; Liu Xiaoqiang, the former deputy general manager of Shaanxi Construction Co., Ltd., has been transferred to the general manager of Shaanxi Water Development Group.
Design Institute and its subsidiaries have won the bid for several projects.
() Announcement, the company and its subsidiaries received the bid-winning notice, and the project names were Anhui () Highway Co., Ltd.’ s 2023 general contracting project of adjusting and refining the design and construction of expressway traffic safety facilities; In 2023, the first bid section of EPC project of new energy projects supporting some expressways in Anhui Province; S40 Section 01 of Ningguo-Jingxian Expressway and S68 Jingde-Jixi Expressway Survey and Design Consulting Service; Design and construction general contracting project of renovation project of Xinqiao International Airport Expressway Monitoring and Management Center Park; Social investor of Xin ‘anjiang tourist channel regulation project franchise project; General contract for design and construction of image reconstruction project of 30 gas stations such as Jiaogang Lake and Lv Wang of Anhui Expressway Petrochemical Co., Ltd.; Special inspection (supervision) service for tunnel of Yongshan-Yanjin Expressway; Central Laboratory of Hefei Section of Huainan-Tongcheng Expressway; Reconstruction and expansion project of Huayang Port Storage Wharf in Wangjiang County-engineering feasibility study and related special topics compilation; Huzhou South Taihu Lake (Xing Wu) General Airport Whole Process Service and Aviation Industrial Park Master Plan Project; Maanshan Expressway Scheme Design Service Procurement Project; Consulting services for site selection and feasibility study of Qingyang General Airport.
Crude oil production has reached a new high () It is estimated that the net profit in 2023 will increase by 58.94%-68.88% year-on-year.
On the evening of January 29th, Zhongman Petroleum announced the pre-increase of performance, and the company predicted that the net profit attributable to shareholders of listed companies would be 800-850 million yuan in 2023, up by 58.94%-68.88% year-on-year.
In 2023, the company focused on Wensu block, aiming at realizing the scale of reserves and rolling production, actively exerting the advantages of integration, and through increasing the combination of exploration and key evaluation, it achieved multiple breakthroughs in new strata and new fields, and basically proved the oil and gas reserves in the upper wall of F1 fault zone in Kekeya Oilfield.
At the same time, Wensu Oilfield climbed to a new level on the basis of the accumulated crude oil production exceeding 1 million tons by intensifying the implementation of horizontal wells, actively carrying out reservoir reconstruction measures and strengthening the production management of oil wells, and the annual crude oil production reached a new high in 2023. The company’s Wensu project achieved a crude oil output of 580,800 tons in 2023, an increase of 146,800 tons over the same period of last year, with a year-on-year increase of 33.82%, and continued to maintain a strong growth trend. (Zhao Ping)
China Track, the major shareholder of Jinchuang Group, completed the reduction of 3,655,500 shares.
() Announcement: China Railway Transportation Co., Ltd. (hereinafter referred to as "China Track"), the non-largest shareholder of the company holding more than 5% of the shares, has reduced its holdings of 3,655,500 shares through centralized bidding and block trading, accounting for 0.47% of the company’s total share capital; As of the disclosure date of this announcement, the time interval of the reduction plan of China Rail, the shareholder of the company, has expired.
() The net profit in 2023 was reduced by 5.5 million to 7.5 million yuan, which plunged by 93.11% to 94.95%.
Yaxing chemical disclosed the announcement of pre-reduction of annual performance in 2023. The company estimated that the net profit attributable to shareholders of listed companies in the reporting period would be 5.5 million yuan to 7.5 million yuan, a year-on-year decrease of 93.11% to 94.95%. The net loss attributable to shareholders of listed companies after deducting non-recurring gains and losses is 130 million yuan to 90 million yuan, from profit to loss year-on-year.
During the reporting period, the company’s production and operation work progressed steadily, and the production capacity continued to show a recovery growth trend since the relocation. However, compared with before the relocation of the company, the depreciation allocation amount of new public works in the factory area was larger; At the same time, during the reporting period, affected by unfavorable factors such as intensified industry competition and weak downstream demand, the net profit after deducting non-recurring gains and losses in 2023 dropped sharply year-on-year.
The case of Pacific Securities v. Ningbo Pinbo and other property damages was rejected by the court.
On the evening of January 29th, Pacific Securities announced that the company had recently received a Civil Judgment from the Higher People’s Court of Zhejiang Province regarding the company’s case against Ningbo Pinbo Equity Investment Partnership (Limited Partnership), and upheld the original judgment.
Pacific Securities said that the creditor’s rights involved in the above cases have been partially paid off, and the company has accrued corresponding asset impairment reserves, which will not have a significant impact on the company’s current profits or future profits. The company’s business operations are normal, and the above litigation matters have no significant impact on the company’s business operations, financial status and solvency.
Guojin Securities completed the issuance of 1.5 billion yuan of corporate bonds.
On the evening of January 29th, Guojin Securities announced that its corporate bonds with an approved amount of no more than 15 billion yuan (including 15 billion yuan) were approved by Shanghai Stock Exchange and registered by China Securities Regulatory Commission. According to the Prospectus for Offering Corporate Bonds to Professional Investors (Phase I) by Guojin Securities Co., Ltd. in 2024, the issuance scale of Guojin Securities’ offering corporate bonds to professional investors (Phase I) in 2024 shall not exceed RMB 1.5 billion (including RMB 1.5 billion).
The bond issuance of this issue ended on January 29th, 2024, and the actual issuance scale was 1.5 billion yuan. In the end, coupon rate was 2.83% and the subscription multiple was 2.64.
Year-on-year growth of 14.7 times to 17.6 times. China Ship expects a large increase in net profit in 2023.
On the evening of January 29th, China Ship released the announcement of pre-increase of annual performance in 2023. According to the announcement, China Shipbuilding expects the net profit attributable to the owners of the parent company to be between 2.7 billion yuan and 3.2 billion yuan in 2023, up 14.7 times to 17.6 times year-on-year.
According to the announcement, the substantial growth of China Ship’s performance in 2023 is mainly affected by the following factors: non-monetary assets exchange gains and losses caused by the disposal of offshore platforms by the company’s subsidiaries and non-recurring gains and losses such as receiving government subsidies; In 2023, the global new shipbuilding market maintained a good development trend as a whole. With the gradual clearing of low-priced ship orders in the early stage, the company’s hand-held order structure continued to improve; Focusing on the annual production task index, the company strengthened production control and improved production efficiency, and its operating income increased significantly year-on-year, exceeding the annual task target.
According to the data recently released by the Ministry of Industry and Information Technology, in 2023, China’s three major shipbuilding indicators all increased year-on-year, ranking first in the world for 14 consecutive years. Among them, the shipbuilding completion was 42.32 million deadweight tons, up 11.8% year-on-year; The volume of new orders received was 71.2 million deadweight tons, up 56.4% year-on-year; By the end of 2023, the volume of hand-held orders was 139.39 million deadweight tons, a year-on-year increase of 32.0%.
According to industry insiders, since 2023, the price of new ships has continued to rise, and the global new shipbuilding market will remain highly active under the support of updated demand. At the same time, the supply of berths is tight at present, and the competitive characteristics of orders gathering to the head enterprises are obvious, which also gives shipping enterprises a certain bargaining space. It is expected that the price of new ships will continue to remain relatively high in 2024.
Three Gorges Energy plans to invest 1 billion yuan with Changjiang Electric Power Co., Ltd. in Tianjin to improve the competitiveness of the regional market.
() Announcement: In order to effectively improve the company’s regional market competitiveness in Tianjin and strengthen the overall planning of Tianjin’s regional business, the company plans to establish a joint venture company, Three Gorges Tianjin Energy Investment Co., Ltd. (Tianjin Nengtou, subject to the registered name of the enterprise) with China () Co., Ltd. (referred to as Changjiang Power) and Three Gorges Capital Holding Co., Ltd. (referred to as Three Gorges Capital) in Tianjin, with an all-round layout of its business in Tianjin, focusing on offshore wind power bases around the Bohai Sea. Three Gorges Energy, Yangtze Power and Three Gorges Capital respectively subscribed 510 million yuan, 340 million yuan and 150 million yuan in cash, accounting for 51%, 34% and 15% of the registered capital of the joint venture company respectively.
The establishment of Tianjin Energy Investment Co., Ltd. with Changjiang Electric Power and Three Gorges Capital is an important measure to implement the company’s development strategy, which will effectively give full play to the professional capabilities and synergistic advantages of each subject in technology, talent and investment, and provide multiple guarantees and strong support for the high-quality development and construction of Tianjin’s new energy business.
Shaanxi Construction Co., Ltd.: Elected Chen Qi as the chairman of the eighth board of directors of the company.
On the evening of January 29th, Shaanxi Construction Co., Ltd. announced that on January 29th, 2024, the 16th meeting of the 8th Board of Directors of the Company reviewed and approved the Proposal on Electing the Chairman of the Company. According to the Company Law and the Articles of Association of Shaanxi Construction Engineering Group Co., Ltd., all directors unanimously agreed to elect Chen Qi as the chairman of the eighth board of directors of the company, with a term of office from the date of deliberation and approval at this board meeting to the date of expiration of the eighth board of directors.
Three Gorges Energy plans to transfer 100% equity of Urumqi Pumping and Storage Company to Three Gorges Group at a price of 105 million yuan.
Three Gorges Energy announced that in order to smoothly promote the preliminary work of Dabancheng Pumped Storage Power Station project in Xinjiang and promote the high-quality development of pumped storage business, it is planned to transfer 100% equity of Three Gorges New Energy Urumqi Pumped Storage Power Generation Co., Ltd. (hereinafter referred to as Urumqi Pumped Storage Company) held by the company to China Yangtze River Three Gorges Group Co., Ltd. (hereinafter referred to as Three Gorges Group) at a price of 105 million yuan.
Lexin Technology: The chairman proposed to buy back the company’s shares from 50 million yuan to 100 million yuan.
Lexin Technology announced that on January 29, 2024, the board of directors of the company received a letter from TEO SWEEANN (Zhang Ruian), the controlling shareholder, actual controller and chairman of the company, on proposing Lexin Information Technology (Shanghai) Co., Ltd. to buy back the shares of the company. TEO SWEE ANN proposed that the company buy back the company’s shares through centralized bidding transaction for employee stock ownership or equity incentive plan. The total amount of repurchase funds is not less than 50 million yuan and not more than 100 million yuan; The repurchase price shall not exceed 120 yuan/share.
Lexin Technology said that TEO SWEE ANN proposed to buy back shares through centralized bidding transaction based on its confidence in the company’s future sustainable development and recognition of the company’s value, in order to safeguard the interests of investors, enhance investors’ confidence in the company’s investment, and promote the stable and healthy development of the company, effectively combining the interests of shareholders, the company’s interests and the personal interests of employees.
Shengtun Mining expects to make provision for impairment of 306 million yuan in 2023.
() Announcement, the company’s provision for impairment this time is included in the subjects of asset impairment loss and credit impairment loss. The total impact on the company’s total consolidated profit in 2023 is-306 million yuan (unaudited).
Lexin Technology: It is planned to buy back shares at a price of RMB 50 million to RMB 100 million.
Lexin Technology announced that the company intends to buy back shares by centralized bidding transaction for employee stock ownership or equity incentive plan. The repurchase amount is not less than 50 million yuan and not more than 100 million yuan; The repurchase price shall not exceed 120 yuan/share.
TBEA: The holding company plans to invest in Xi ‘an digital factory project.
TBEA announced that TBEA Xi ‘an Electric Technology Co., Ltd., the company’s holding company, plans to invest in the construction project of 5G digital factory and science and technology research and development building in Xi ‘an Industrial Park, with a total investment of 1,163,244,400 yuan.
Ji Xiang shares’ pre-loss performance in 2023 both declined.
() On the evening of January 29th, the announcement of pre-loss of annual performance in 2023 was released. The company expects to achieve a net profit of-270 million yuan to-340 million yuan in 2023, compared with 492 million yuan in the same period of last year; It is estimated that the non-net profit deducted in 2023 will be-290 million yuan to-370 million yuan, compared with 435 million yuan in the same period of last year.
As for the main reason for the pre-loss of performance, Ji Xiang said that in 2023, due to the slowdown in the growth rate of the new energy vehicle market, the upstream resource supply capacity was released, the price of lithium salt fell all the way, and the industry as a whole was in a downturn. Yongshan Lithium Industry actively takes measures to reduce the risks brought by the market downturn by accelerating shipment, increasing the proportion of processing business and purchasing lithium ore at the right time. Among them, the lithium salt plate achieved profitability in the first quarter of 2023. Since the second quarter of 2023, the competition in the lithium salt market has intensified, and the sales volume is less than expected at the beginning of 2023. At the same time, the rapid decline in the unit price of products has led to a low gross profit margin of products, which has led to a loss in the lithium salt sector business throughout the year. During the reporting period, the lithium sector is expected to achieve a net profit of-120 million yuan to-160 million yuan.
In addition, the company’s molybdenum plate business was affected by the deep and frequent fluctuations in the prices of products and raw materials, and the gross profit margin of products was low, and the inventory depreciation loss increased, resulting in a large loss in the company’s molybdenum business.
Ji Xiang Co., Ltd. was originally a large-scale molybdenum enterprise. Influenced by macroeconomic fluctuations, changes in upstream and downstream market demand and other factors, the molybdenum industry fluctuated greatly, which led to great fluctuations in the company’s performance. Based on this background, Ji Xiang has tried to enter a new field in recent years.
In January 2022, Ji Xiang Co., Ltd. completed the acquisition of the equity of Yongshan Lithium Industry, actively strategically laid out the lithium salt business, and increased the lithium industry sector in its main business. At the end of June, 2022, the first-phase project of Yongshan Lithium Industry was put into operation. In October of the same year, the annual production capacity of 15,000 tons of battery-grade lithium hydroxide and 10,000 tons of battery-grade lithium carbonate was formed, and the core cathode materials were supplied to customers in batches. The second phase of the project was officially started in April 2023.
It should be pointed out that in the first half of 2023, Ji Xiang’s share performance turned a profit year-on-year, which was mainly due to the contribution of the lithium salt sector. However, the third quarterly report of Ji Xiang Co., Ltd. in 2023 showed that the company’s net profit suffered a loss of 196 million yuan due to the sharp drop in the price of lithium salt products and the huge fluctuation in the market price of molybdenum products.
On the evening of October 20, 2023, Ji Xiang Co., Ltd. announced the abnormal fluctuation of stock trading. The operating period of the company’s lithium sector was short, the competition pattern of the lithium industry was fierce, and the overall price of lithium products fluctuated greatly, which led to operational risks in the industry.
It is worth mentioning that Yang Feng, chairman and general manager of Ji Xiang Co., Ltd., said at the performance briefing in 2022 that the operation of molybdenum industry is indeed inefficient compared with that of lithium industry, but at this stage it accounts for a relatively high proportion of overall revenue. At present, it will still maintain the pattern of dual main businesses. After the revenue proportion of lithium industry rises, it will consider making appropriate arrangements and adjustments to molybdenum industry at the right time.
As early as September 2022, Ji Xiang announced that it would sell its 100% equity of Xisha Degai Molybdenum Industry, a wholly-owned subsidiary, to Shanghai Yongju, a wholly-owned subsidiary of Ningbo Jutai, the controlling shareholder of the company, for 580 million yuan in cash. The business scope of Xisha Degai Molybdenum Industry includes molybdenum mining and dressing (subject to the validity of mining license) and sales of molybdenum products.
Ji Xiang said that after the completion of the above transaction, the company will further focus on the processing and production of lithium salt and molybdenum products, optimize the company’s business and product structure, promote the positive transformation of the company’s business, and improve the company’s anti-risk ability and sustainable profitability.
According to the announcement of Ji Xiang on November 10, 2023, as of November 9, 2023, Shanghai Yongju has paid off the above-mentioned 580 million yuan equity transfer and paid the corresponding overdue interest.
Strong demand for photovoltaic brackets. CITIC Bo’s net profit in 2023 is expected to increase by nearly 7 times.
On the evening of January 29th, CITIC Bo announced that, according to the preliminary calculation of the financial department, it is estimated that the annual net profit in 2023 will be about 354 million yuan, an increase of about 310 million yuan, an increase of about 696.70%. Deducted non-net profit was about 313 million yuan, an increase of about 2270.60% year-on-year.
According to the data, CITIC Bo’s main business is the design, research and development, production and sales of photovoltaic bracket systems. Last year, as an important part of the photovoltaic industry, the market demand for photovoltaic brackets continued to expand with the growth of photovoltaic installed capacity.
For performance growth, CITIC Bo said that the global market for photovoltaic centralized ground power stations has strong demand for new installed capacity, and the company has a leading comprehensive advantage in the field of photovoltaic bracket system segmentation. At the same time, relying on the advantages of the global marketing service network and efficient supply and delivery system, the company’s photovoltaic bracket product business has developed rapidly, achieving double growth of the company’s operating income and net profit.
At the same time, CITIC Bo said that the company’s previous strategic layout in the photovoltaic bracket industry gradually showed results in 2023, and orders also increased, effectively supporting the growth and sustainability of the company’s main business. As of December 31, 2023, the company’s orders in hand totaled about 4.7 billion yuan, including about 3.6 billion yuan for tracking system, 1 billion yuan for fixed bracket and 100 million yuan for others.
As for the substantial increase in non-net profit deduction, CITIC Bo explained that during the reporting period, the non-operating profit and loss increased compared with the same period of last year due to the influence of changes in the fair value of transactional financial assets (forward foreign exchange locking business), government subsidies included in the current profit and loss, the profit and loss of assets entrusted by others to invest or manage, and the reversal of impairment provision for receivables that were separately tested for impairment.
It is worth mentioning that in 2023, CITIC Bo also strengthened cooperation with well-known photovoltaic enterprises at home and abroad, and further expanded its market share through cooperative research and development and joint promotion. At the same time, actively lay out overseas markets, set up overseas subsidiaries and establish sales channels.
Recently, CITIC Bo announced that the company has signed a strategic cooperation agreement with Alpon Energy in Turkey. In the future, the two sides will cooperate in photovoltaic power plant project management, technical service cooperation, product installation and commissioning in the local market to ensure the full-cycle operation of CITIC Bo’s projects in the Turkish market and deepen the Turkish renewable energy market. Through the signing of this strategic cooperation agreement, the two sides will jointly promote the common growth of the solar energy market in Turkey and its neighboring countries in the future.
Recently, CITIC Bo has publicly stated that at present, CITIC Bo has four manufacturing bases around the world, with an annual delivery capacity of 30GW. At present, its products have served more than 1,500 projects in more than 40 countries. In 2024, CITIC Bo will continue to improve product and supply security, promote supply-side structural reform and promote economic development.
From the perspective of the secondary market, the photovoltaic sector has recently ushered in a sustained rebound. Industry analysis believes that the main reason is that the recent overseas PV inventory has been significantly reduced. () According to the research report, it is estimated that the new installed capacity of photovoltaic in China will increase by about 15% in 2024. The overseas market demand is expected to be fully stimulated by the drop in component prices. It is estimated that the installed capacity will increase by 465-485 GW, up by about 20% year-on-year. Hua Fu Securities believes that the triple efforts of China, the United States and Europe are accompanied by the rapid growth of emerging markets. It is estimated that the installed photovoltaic capacity in the world will be 470GW in 2024, with a year-on-year growth rate of 24%, and the demand is still resilient.
Sifang Technology: It is planned to issue convertible bonds not exceeding RMB 1.023 billion.
() Announcement, the company plans to issue convertible bonds to unspecified objects, with the total amount of funds raised not exceeding 1,023,395,000 yuan, and plans to invest in the project of enhanced polyurethane cryogenic composite materials for LNG thermal insulation system, the production project of special tank storage and transportation equipment, and the construction project of green and energy-saving new materials engineering technology research center.
Heideman, Zhejiang: It is estimated that the performance in 2023 will be announced.
Zhejiang Heideman announced that the company is conducting preliminary accounting for its performance in 2023, and the specific financial data will be published after being audited by certified public accountants. During the reporting period, the company increased the iterative upgrade of products, and sold some stock models through promotion, which had an impact on the gross profit margin. At the same time, the company has also increased its market development and maintenance efforts, and the exhibition and publicity expenses have increased year-on-year. In order to develop high value-added products, the company’s R&D personnel recruitment and R&D expenditure increased year-on-year. The above forecast data are only preliminary accounting data, and the specific and accurate financial data are subject to the audited 2023 annual report officially disclosed by the company.
Longji Green Energy: The chairman of the board plans to increase its holdings for the first time on January 30th.
Longji Green Energy announced that the company had previously announced that Chairman Zhong Baoshen planned to increase the company’s shares within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to increase its holdings for the first time on January 30, 2024, and will continue to increase its holdings according to the above increase plan.
Witten Electric’s main business is steadily improving, and its net profit in 2023 increased by 57.34% to 74.50% year-on-year.
On the evening of January 29th, Witten Electric announced the pre-increase announcement of its annual performance in 2023. The company predicted that the net profit attributable to the owners of the parent company would reach 110 million yuan to 122 million yuan this year, which will increase by 40,087,000 yuan to 52,087,000 yuan compared with the same period of last year, with a year-on-year increase of 57.34% to 74.50%. It is estimated that the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses will reach 98 million yuan to 110 million yuan in 2023, which will increase by 31,694,900 yuan to 43,694,900 yuan compared with the same period of last year (legally disclosed data), with a year-on-year increase of 47.80% to 65.90%.
The announcement shows that during the reporting period, the company’s business developed steadily and the overall development trend was good. The company closely focuses on the three major businesses of power distribution equipment, new photovoltaic materials and energy storage systems, and constantly consolidates the industrial development layout. On the basis of the gradual improvement of production capacity, we will continue to increase investment in research and development, product development, strengthen the construction of sales team and strengthen market promotion.
It is reported that the sales of main products of Witten Electric, such as high and low voltage bus, pv ribbon and energy storage system, increased, which promoted the steady growth of the company’s operating performance.
Longji Green Energy: the concerted action of the controlling shareholder received the advance notice of administrative punishment.
Longji Lvneng announced on the evening of January 29th that Li Chun ‘an, the concerted action person of the company’s controlling shareholder, received the Notice of Administrative Punishment in advance issued by Liaoning Securities Regulatory Bureau on January 29th. As the chairman of Liancheng CNC, the target of Shijin Technology’s fixed issuance, Li Chun ‘an leaked inside information to Zhao Mouping before the inside information was made public, which constituted an act of leaking inside information. Liaoning Securities Regulatory Bureau plans to make the following decision: impose a fine of 500,000 yuan on Li Chun ‘an. Longji Green Energy said that the subject of punishment involved in the above-mentioned "Notice of Administrative Punishment in advance" is only Li Chun ‘an, and the subject of insider trading involved in the matter of punishment is not the company’s stock, and it does not involve related matters of the company. The above administrative penalties will not affect the normal operation, standardized operation and financial status of the company.
Huitong shares: In 2023, the non-net profit was pre-increased by 236.34%-297.07%, and the income in new markets increased steadily.
On the evening of January 29th, Huitong announced the pre-increased performance, and it is estimated that the net profit returned to the mother will reach 143 million yuan to 161 million yuan in 2023, an increase of 141.50% to 172.52% compared with the same period of last year (legally disclosed data). It is estimated that the net profit of non-returning to the mother will be 102 million yuan to 120 million yuan, an increase of 236.34% to 297.07% over the same period of last year.
According to the announcement, the main reason for the growth of Huitong’s performance in 2023 is that the company seized the opportunity of macro-market structural adjustment, continued to increase investment in new markets such as new energy vehicles and consumer electronics, and achieved steady growth in income in related fields. The change in market structure promoted the company’s high-quality development and at the same time promoted the overall profit growth of the company. At the same time, by focusing on the application scenarios of major customers, the company effectively solved the pain points of customers, increased investment in innovative research and development, strengthened the improvement of product strength and solution capability, promoted the iterative innovation of products in the company’s advantageous business areas, and developed a number of products with leading industry and stable quality, which drove the growth of the company’s profits. In addition, the company adheres to the concept of achieving customers, promotes customer-oriented value flow carding, realizes efficiency improvement in the whole value chain operation, and at the same time comprehensively introduces the concept of lean, promotes cost reduction for all employees, and further enhances the company’s profitability.
Huitong Co., Ltd. is mainly engaged in the research and development, production and sales of polymer modified materials, and strategically laid out the new energy sector business, and built a wet separation film project for lithium batteries with an annual output of 1.7 billion square meters.
At present, China’s high-end modified materials market is still dominated by imports. In order to break the monopoly in the field of special engineering materials and realize the goal of import substitution, Huitong Special Materials Technology Co., Ltd. was established by foreign investment to build an integrated platform of "polymerization-modification" of special engineering materials. The company’s special engineering materials have been mass-produced and sold, and the annual production capacity of polymer products can reach 3,000 tons. At the same time, the company vigorously carried out the research and development of international high-end modified materials, and developed a number of imported substitute products, including long carbon chain nylon for the surface coating of dishwasher bowls and baskets; PPS, a special engineering material with excellent properties such as high strength and creep resistance, has reached CTI0 level. Flame retardant PC and alloy materials with good high and low temperature toughness, outdoor aging resistance and solvent stress cracking resistance.
In addition to increasing research and development efforts to achieve import substitution, the company also seized the opportunity of high-quality development and green low-carbon cycle transformation, and actively practiced the strategy of green design and green intelligence to create low carbon. Comprehensively promote the layout of the whole industrial chain of PCR products, carry out strategic cooperation with upstream suppliers such as zero-carbon products, continuously expand the use of PCR modified plastics, complete the certification of recycled materials content of more than 100 products, obtain OBP certification, provide product carbon accounting support for many customers, and continuously promote the construction of the company’s product carbon accounting database.
In addition, the company continues to optimize and upgrade MES, QMS and WMS systems to promote standardization, transparency and dataization of production processes; Through the optimization of manufacturing production line and the promotion of three-dimensional library project, the company has continuously improved its intelligent manufacturing management level, realized the intelligent collaboration of man-machine material method ring, and achieved multiple goals such as efficiency improvement and cost reduction.
Based on the business data platform, the company has built four platforms, namely, customer service, R&D management, order delivery and business analysis, to realize the visualization of the whole LTC process and promote the company’s new breakthrough from "manufacturing" to "intelligent manufacturing". (Qi Hening)
Fulai New Material Yantai Fuli Phase I (Second Line) Project entered trial production.
() On the evening of January 29th, it was announced that the second production line of Yantai Fuli New Materials (Phase I) project invested and built by the holding subsidiary had completed the equipment installation and commissioning and entered the trial production stage.
Yantai Fuli New Materials (Phase I) Project has an annual production capacity of about 100,000 tons of BOPP functional films. The first production line of the project was successfully put into production in July 2023, with a designed annual production capacity of about 50,000 tons of BOPP functional films, which has reached the designed production capacity. At present, the second production line of the project has completed the equipment installation and debugging, and entered the trial production stage, with the designed annual production capacity of about 50,000 tons of BOPP functional film.
Fulai New Materials’ main business is functional coating composite materials, which are mainly divided into three categories: advertising inkjet printing materials, label printing materials and electronic functional materials. Yantai Fuli New Materials’ main business is film research and development, production and sales.
According to the announcement, after the project is fully put into production, the company’s comprehensive cost and raw material supply will be further reduced, which will have a positive impact on the company’s future operating performance and further stabilize the company’s dominant position in the industry. (Wang Weili)
() The net profit in 2023 was reduced by 14 million yuan to 21 million yuan, which plummeted by 93.34% to 95.56%.
Suli shares disclosed the announcement of pre-reduction of 2023 annual results. The company expects that the net profit attributable to shareholders of listed companies during the reporting period will be 14 million yuan to 21 million yuan, a year-on-year decrease of 93.34% to 95.56%. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 15 million yuan to 22.5 million yuan, a year-on-year decrease of 92.78% to 95.19%.
In 2023, the main reason for the decrease in performance compared with the same period was: due to the cyclical fluctuation of the industry and changes in market supply and demand, the market price of the company’s main products continued to be at a low level and the sales of some products declined, which led to the decline in the profit margin of the company’s products.
Chairman Longji Green Energy plans to increase its holdings for the first time on January 30th.
Longji Green Energy announced that the company had previously announced that Chairman Zhong Baoshen planned to increase the company’s shares within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan. On January 29, 2024, the company received a notice from Zhong Baoshen that it planned to increase its holdings for the first time on January 30, 2024, and will continue to increase its holdings according to the above increase plan.
[Company Report]
Weilai signed a strategic cooperation agreement with Longji Green Energy
According to Weilai Guanwei news, on January 3, Weilai and Longji Green Energy jointly announced the signing of a strategic cooperation agreement. The two sides will work closely together to promote the use of green and clean energy for photovoltaic power generation in charging and replacing power stations, build an industry-leading integrated station for optical storage, charging and replacing, and cooperate in promoting the interaction between distributed photovoltaic and V2G vehicle network, and establishing relevant industry standards of "carbon neutrality in travel".
Weilai holds hands with Longji Green Energy to promote photovoltaic power exchange station.
Weilai’s pace of foreign cooperation is quietly accelerating. Following the establishment of "Power Exchange Partners" with Changan and Geely, Weilai has recently extended its cooperation tentacles to the leading photovoltaic industry.
On January 3rd, Weilai (09866) and Longji Green Energy jointly announced the signing of a strategic cooperation agreement. The two sides will work closely together to promote the use of green and clean energy for photovoltaic power generation in charging and replacing power stations, build an industry-leading integrated station for optical storage, charging and replacing, and cooperate in promoting the interaction between distributed photovoltaic and V2G vehicle networks, and establishing relevant industry standards for "carbon neutrality in travel" to help realize the goal of "peak carbon dioxide emissions and carbon neutrality" in the transportation field. (Securities Times Han Zhongnan)
ST Tiancheng received the inquiry letter of performance forecast.
() According to the announcement, on January 29th, 2024, it received the "Letter of Inquiry on Matters Related to the Performance Forecast of Guizhou Changzheng tiancheng holdings Co., Ltd." issued by Department II of Listed Company Management of Shanghai Stock Exchange.
In the fourth quarter, Anhui Construction Engineering Co., Ltd. signed a new contract worth 49.55 billion yuan, a year-on-year increase of 31.95%.
() Announcement: In the fourth quarter of 2023, the company signed 133 new contracts, with a new contract amount of 49.55 billion yuan, with a year-on-year increase of 31.95%. From the first quarter to the fourth quarter of 2023, a total of 551 new contracts were signed, with a new contract value of 151.07 billion yuan, an increase of 13.81% year-on-year.
Anhui Construction Engineering Subsidiary won several projects.
Anhui Construction Engineering announced that recently, the company’s subsidiaries Anhui Highway and Bridge Engineering Co., Ltd., Anhui Construction Engineering Sanjian Group Co., Ltd., Anhui Water Resources Development Co., Ltd., Anhui Construction Engineering Transportation and Navigation Group Co., Ltd. and Anhui Sanjian Luzhou Engineering Co., Ltd. received the bid-winning notice.
It is reported that the bid-winning projects are bid YQB2(YQTJ-02) of subgrade and pavement construction in Anqing-Qianshan section (Yueshan-Qianshan section) of S22 Tiantian Expressway; New Development Bank loans the second phase (K5+800-K10+860) of the new construction project of S334 Eshan Road East Extension (Yanjiang Expressway to Wuxuan Expressway) of Anhui Highway Development Project; Hefei Future Great Science City Area Project (Phase I) integrates investment, construction and operation; Construction of Lanyuan Yuefu Project; S18 Bid Section -4 of Subgrade and Pavement Project of Hefei Section of Nanjing-Hefei Expressway.
() The net profit in 2023 was reduced by 420 million yuan to 500 million yuan, plunging by 67.99% to 73.11%.
Blum Oriental disclosed the announcement of pre-reduction of 2023 annual results. The company expects the net profit attributable to shareholders of listed companies to be 420 million yuan to 500 million yuan during the reporting period, down 67.99% to 73.11% year-on-year. The net profit attributable to shareholders of listed companies, after deducting non-recurring gains and losses, ranged from-20 million yuan to-10 million yuan, turning from profit to loss year-on-year.
It is reported that the pre-reduction of the company’s performance is mainly due to the increasing downward pressure of the global economy in 2023, the continued sluggish downstream consumer demand, and the impact of overseas clothing brands’ destocking. The company’s overall orders are insufficient, the capacity utilization rate declines, and the product price declines year-on-year, resulting in a decline in the profit of the company’s main business.
Chengdu Gas Company, which secretly set up concealed pipes to discharge water pollutants, received the decision of administrative punishment.
() A few days ago, it was announced that Chengdu Liquefied Natural Gas Co., Ltd. (hereinafter referred to as "Liquefied Company"), a wholly-owned subsidiary of the company, received the administrative penalty decision issued by Chengdu Ecological Environment Bureau on January 25, 2024.
The Chengdu Bureau of Ecology and Environment conducted a law enforcement inspection on the "Sichuan Tire and Rubber (Group) Co., Ltd. Natural Gas Distributed Energy Project" of Liquefied Company, and found that the Liquefied Company discharged water pollutants in the project. According to the fourth paragraph of Article 42 of People’s Republic of China (PRC) Environmental Protection Law and Article 39 of People’s Republic of China (PRC) Water Pollution Prevention Law, Chengdu Eco-environment Bureau fined the liquefaction company 177,100 yuan.
According to official website of Chengdu Ecological Environment Bureau, on August 31st, 2023, the law enforcement officers of Longquanyi detachment of Chengdu Ecological Environment Protection Comprehensive Administrative Law Enforcement Corps conducted a law enforcement inspection on "Sichuan Tire & Rubber (Group) Co., Ltd. Natural Gas Distributed Energy Project" of Chengdu LNG Co., Ltd. located at No.568, Chuanxiang Road, Yangma Street, East Chengdu New District, according to the double random clues, and found that the liquefaction company had committed the following environmental violations: discharging water pollutants by means of evading supervision.
() The net profit in 2023 was reduced by 80 million to 110 million yuan, which plunged by 83.67% to 88.13%.
Changyuan Group disclosed the announcement of pre-reduction of annual performance in 2023. The company expects the net profit attributable to shareholders of listed companies to be 80 million yuan to 110 million yuan during the reporting period, a year-on-year decrease of 83.67% to 88.13%. The net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 50 million yuan to 74.5 million yuan, a year-on-year decrease of 0.36% to 33.13%.
During the reporting period, while consolidating the market position of the main network business, it continuously explored new markets at home and abroad, and its operating income grew steadily, increasing by about 900 million yuan compared with the same period of last year, mainly due to the increase in sales income of smart grid equipment and new energy projects, especially engineering general contracting business. In addition, the investment income decreased by about 1.16 billion yuan compared with the same period of last year.
() A shareholders’ meeting will be held on February 19th to consider the proposal that the controlling shareholders provide new loans and related transactions to the holding subsidiaries of the company.
Samsung New Materials announced that the first extraordinary shareholders’ meeting will be held on February 19, 2024, and online voting will be held on the same day. Date of record falls on February 2nd, and investors who hold shares of Samsung New Materials can vote after the market closes on that day.
Meeting place: meeting room on the third floor of Zhejiang Samsung New Materials Co., Ltd., No.333 Hanghai Road, Yuyue Town, Deqing County, Huzhou City, Zhejiang Province.
A total of 1 proposal was audited at this general meeting of shareholders, as follows:
1. Proposal on Providing New Loans and Related Transactions to the Company’s Holding Subsidiaries by Related Parties of the Controlling Shareholders.
Baosteel packaging: It is planned to buy back shares at a price of RMB 50 million to RMB 100 million.
On January 29th, baosteel packaging announced that it plans to buy back its shares at a price of 50-100 million yuan, which will be used for the continuous implementation of the equity incentive plan in the future. The upper limit of the repurchase price is planned not to exceed 7.66 yuan/share.
Baosteel packaging: It is planned to buy back the company’s shares of RMB 50 million to RMB 100 million.
Baosteel packaging announced that it plans to buy back 50-100 million yuan of shares of the company, which will be used for the continuous implementation of the equity incentive plan in the future, and the repurchase price will not exceed 7.66 yuan/share.
Eco-Optoelectronic Power Co., Ltd. pre-reduced its net profit by 12 million to 18 million yuan in 2023, plummeting by 74.40% to 82.94%.
Eko Optoelectronics disclosed the announcement of pre-reduction of 2023 annual results. The company expects the operating income in the reporting period to be 220 million yuan to 250 million yuan, a year-on-year decrease of 4.82% to 16.24%. The net profit attributable to the owners of the parent company was 12 million yuan to 18 million yuan, a year-on-year decrease of 74.40% to 82.94%. The net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was 6 million yuan to 9 million yuan, a year-on-year decrease of 84.59% to 89.73%.
It is reported that due to various factors such as the global economic slowdown, the overall macro-economy and the cyclical changes of lithium batteries, customer demand has declined, the company’s orders have decreased and industry competition has intensified, resulting in a decline in the company’s sales and gross profit margin. In addition, during the reporting period, the expenses for renovation and renovation of newly leased production and office buildings and investment in new production line equipment increased related expenses and fixed costs; In order to maintain the company’s competitive advantage in the market, the company continues to carry out technological innovation and constantly explore market areas and customer groups, resulting in an increase in the company’s research and development expenses and operating costs; In the first half of 2023, new equity incentives were added, and the relevant share payment fees were confirmed.
Lexin Technology completed the repurchase of 1.06% shares at a cost of 80,025,900 yuan.
Lexin Technology announced that as of January 29, 2024, the company had repurchased 858,100 shares of the company through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 1.06% of the company’s total share capital of 80,789,724 shares. The highest price of the repurchase transaction was 100.00 yuan/share, and the lowest price was 81.61 yuan/share, and the total amount of funds paid was 8,002.50 yuan. The amount of shares repurchased this time has reached the upper limit, and the repurchase plan has been implemented.
China Ship is expected to have a net profit of 2.7 billion yuan to 3.2 billion yuan in 2023, with an explosive increase of 1470.95% to 1761.87%.
According to the announcement of the pre-increase of the annual performance of China Shipbuilding Co., Ltd. in 2023, the company expects the net profit attributable to the owners of the parent company to be between 2.7 billion yuan and 3.2 billion yuan, increasing by 1470.95% to 1761.87% year-on-year. It is estimated that the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses will be between-500 million yuan and 0 yuan in 2023.
During the reporting period, due to the exchange gains and losses of non-monetary assets arising from the disposal of offshore platforms by subsidiaries of the company and the receipt of government subsidies, the company’s non-recurring gains and losses in this period were about 3.2 billion yuan, compared with 2.921 billion yuan in the same period of last year; At the same time, in 2023, the global new shipbuilding market maintained a good development trend as a whole. With the gradual clearing of low-priced ship orders in the early stage, the company’s hand-held order structure continued to improve; Focusing on the annual production task index, the company strengthened production control and improved production efficiency, and its operating income increased significantly year-on-year, exceeding the annual task target. Due to the comprehensive influence of the above factors and the low performance index of the company in the same period of last year, the company’s performance in this period has increased significantly compared with the same period of last year.
Some directors and senior executives of Shengmei Shanghai increased their holdings by 95,700 shares.
Shengmei Shanghai announced that by January 29th, 2024, the company’s directors, general manager Wang Jian, deputy general manager Chen Fuping and secretary of the board of directors Luo Mingzhu had increased their holdings of 95,700 shares by centralized bidding through the trading system of the Shanghai Stock Exchange, accounting for 0.0220% of the company’s total share capital, with a total increase of 7,754,800 yuan, which has exceeded 50% of the lower limit of 9 million yuan in this increase plan. The increase plan has not yet been implemented.
The film market recovers. Hengdian Film and Television is expected to turn a profit in 2023.
On the evening of January 29th, () announced that it is estimated that the net profit attributable to shareholders of listed companies will be 135 million yuan to 180 million yuan in 2023, which will turn losses into profits.
As for the main reasons for the pre-earnings, Hengdian Film and Television said that in 2023, the operating environment of the cinema industry improved, the national film market recovered, the supply side, the projection side and the demand side all improved significantly compared with the same period of last year, the high-quality content continued to be supplied, and the normal pace of film booking and announcement was maintained. The box office performance in the Spring Festival and summer slots was outstanding, the audience’s demand for watching movies was released, the number of people watching movies and the attendance rate increased, and the company’s projection business income and others increased.
Xiang Kai, a young playwright and director in China, said in an interview with Securities Daily: "It is expected that the market will show a strong recovery in 2024, and it is expected to usher in a peak."
In the context of the rising market boom and the continuous concentration of the industry, Hengdian Film and Television said at a recent performance briefing: "The company has established a good strategic cooperative relationship with well-known commercial real estate companies and commercial management companies, and has sufficient cinema project reserves. It plans to build 30 to 50 new direct-operated cinemas every year. By enhancing the brand influence of Hengdian Film and Television, we will improve the service quality of Hengdian Cinema, strengthen the publicity of the resource advantages of Hengdian Cinema and attract more cinemas to join Hengdian Cinema. "
In addition, from the perspective of its own development, in 2023, Hengdian Film and Television will strengthen its management, continue to reduce costs and increase efficiency, strengthen internal control and enhance its comprehensive competitiveness. The operation of the projection business and the content sector is improving.
In fact, in recent years, the company has made great efforts to expand to the upstream of the industrial chain, and made great efforts to produce content and produced a large number of high-quality works. In 2023, Zhejiang Hengdian Film Co., Ltd. (hereinafter referred to as "Hengdian Film"), a wholly-owned subsidiary of Hengdian Film, participated in the production of films such as Wandering Earth 2 and Keeping You Safe, which were released in major schedules and achieved good social and economic benefits.
"In recent years, Hengdian Film and Television has actively transformed into content output, and its development has advanced by leaps and bounds, and it has achieved good results in film production and distribution." Xiang Kai said.
As the Spring Festival approaches, a number of domestic films are scheduled to be released in the Spring Festival file one after another, including three films produced by Hengdian Film Co., Ltd., Pegasus 2, Bears Coming and Going, Reversing Time and Space, and Viva La Vida. Pegasus 2 has been predicted as the box office champion of this Spring Festival file by many film critics.
Feng Yangyang, an expert on communication planet App, told the Securities Daily reporter: "Hengdian Film and Television emphasizes high-quality content in its distribution business, which is in line with the demand for high-quality works in the current film market. In recent years, the company has successfully launched a number of high-quality films, accumulating a good reputation and market influence. In the future development, Hengdian Film and Television is expected to continue to maintain its growth momentum and its market share is expected to further expand. "
It is reported that Hengdian Film and Television still reserves a number of investment films, and constantly strengthens the synergy between the content plate and the cinema plate, and invests in high-quality film and television projects with the help of professional perspectives and the advantages of cinema channels.
Chairman Longji Green Energy plans to implement the first increase in holdings today.
On the evening of January 29th, Longji Green Energy announced that on January 29th, the company received a notice from Chairman Zhong Baoshen that it planned to increase its holdings for the first time on January 30th, 2024, and will continue to implement its holdings plan.
According to the previous disclosure, Zhong Baoshen plans to increase the company’s shares in a way allowed by the Shanghai Stock Exchange system within 12 months from October 31, 2023, with an increase of not less than 100 million yuan and not more than 150 million yuan.
"At present, both the price of the photovoltaic industry chain and the performance of the secondary market are in the downward stage. Longji Green Energy is the leader of the photovoltaic industry, and its chairman’s increase in holdings has obviously boosted the industry." Dr. Ding Bingzhong, a partner of Shanghai Jimao Assets, told the Securities Daily reporter.
According to the performance forecast recently released by listed companies in the photovoltaic industry chain, the performance of many listed companies declined in the fourth quarter of last year, among which the silicon wafer leader () is expected to lose 1.388 billion yuan to 1.988 billion yuan in the fourth quarter of last year.
"Since 2023, the prices of products in all aspects of the photovoltaic industry chain have continued to decline, especially in the second half of the year. The prices of silicon materials, silicon wafers and components have fallen sharply. Although the installed capacity increased substantially last year, the profits of the industry chain have been severely squeezed." Wang Tieshan, director of the Industrial Development and Investment Research Center of Xi ‘an Engineering University, said in an interview with a reporter from Securities Daily.
Longji Green Energy recently said in an institutional survey that from the fourth quarter of 2023 to the present, the price of the photovoltaic industry chain has dropped to a very irrational position, which is not conducive to the long-term healthy development of the photovoltaic industry.
According to the reporter, with the continuous decline in the price of photovoltaic industry chain, some enterprises have begun to control production and reduce production.
"From the current situation, the intensified market competition caused by staged overcapacity will continue for some time. Some enterprises with insufficient cost control ability and backward production capacity will face the risk of being eliminated, while some enterprises with advantages in technology and cost control will be more competitive, which is conducive to the healthy development of the industry." Wang Tieshan said.
Longji Green Energy said that since the fourth quarter of 2023, enterprises in different manufacturing sectors have announced the pace of delaying production expansion. If the profit pressure of the industry continues, there may be a general phenomenon of delaying production expansion, which can restrain the escalation of oversupply pressure to some extent. At the same time, the iteration of battery technology is accelerated, and new technologies such as TOPCon and BC are accelerating to replace P-type PERC technology, and the corresponding backward production capacity will also be cleared, which will promote the gradual improvement of the supply and demand pattern of the industry.
"After the price of the industrial chain has been falling all the way, some enterprises will inevitably withdraw from the industry or reduce production. As the industry leader, Longji Green Energy has obvious competitive advantages and is expected to usher in new development opportunities and its fundamentals will be improved. " Ding Bingzhong analyzed that this may also be the confidence of its chairman in this increase.
"From the historical experience, the development of the photovoltaic industry is characterized by periodic fluctuations, so after a period of trough, it is expected to usher in new development opportunities. As the global attention to renewable energy continues to increase, the demand for photovoltaic market is expected to continue to grow. " Zhu Keli, executive director of China Information Association, said in an interview with a reporter from Securities Daily.
The controlling shareholder will be forced to take Geng Xing shares or change hands for the fourth time.
On January 29th, () announced that 79,929,600 shares held by Zhonggeng Group, the controlling shareholder, would be subject to judicial auction, accounting for 34.71% of the company’s total share capital. This move may lead to the change of the actual controller and controlling shareholder of the company, or it may make the company become an actual controller.
This also means that after 7 years of throwing 2 billion yuan into Geng Xing shares, Zhong Geng Group, a Fujian-based housing company, will finally leave. And where will Geng Xing shares, which have changed hands three times since listing and have poor management, go in the future?
Facing judicial auction
According to the announcement of Geng Xing shares, the company recently learned from the judicial assistance execution platform of Shanghai Stock Exchange and verified by Zhonggeng Group that the Shanghai Financial Court issued the Announcement on Judicial Disposal of Shares on January 26, 2024, which will be publicly handled on the judicial execution platform on February 29, 2024 and March 1, 2024, respectively, and auction 66.6624 million shares of Geng Xing shares held by Zhonggeng Group and 13.2672 million shares.
The reason why the above-mentioned shares held by Zhong Geng Group will face judicial disposal auction is because the stock pledge business of Zhong Geng Group is in breach of contract and Xiamen Trust applied for judicial freezing of 66,662,400 shares of Geng Xing shares held by it. Later, because Zhong Geng Group failed to fulfill the ruling made by Xiamen Arbitration Commission on the above-mentioned case, Xiamen Trust applied to Shanghai Financial Court for compulsory execution.
In addition, as a guarantor, Zhong Geng Group’s subsidiary was applied by Shanghai Guokun Commercial Factoring Co., Ltd. for judicial freezing of its 13,267,200 shares of Geng Xing’s restricted shares due to disputes over factoring contracts. Later, because Zhong Geng Group failed to fulfill the ruling made by Shanghai Higher People’s Court on the above case, Shanghai Guokun applied to Shanghai Financial Court for compulsory execution.
As of the disclosure date of the announcement, Zhonggeng Group holds 81,929,600 shares of listed companies, accounting for 35.57% of the total share capital of listed companies. At present, all its shares are pledged and frozen.
Zhonggeng Group was once one of the representatives of Fujian real estate enterprises and was founded in 1997. Since 2006, the company has begun to make a nationwide layout, leaving Fuzhou and marching into Dalian, and then landing in Jiangsu, Beijing, Chongqing and other places. Following the footsteps of Fujian real estate enterprises such as Shimao and Xuhui, Zhonggeng Group moved its headquarters to Shanghai.
All the way to expansion, Zhonggeng Group has been squeezed into the top 100. In 2018, Zhonggeng Group’s trading amount reached 23.21 billion yuan, ranking 94th among the national housing enterprises.
Zhong Geng Group sought listing for many times, trying to replenish capital through the capital market, but eventually it bought the predecessor of Geng Xing shares, Oriental Silver Star, to achieve listing by curve.
Has changed hands three times.
Geng Xing shares were once known as Oriental Silver Star and *ST Ice Bear (the predecessor of Oriental Silver Star). Since its listing, it has experienced three changes of ownership, but its operation is still lacking, during which there have been infighting dramas for control rights.
The first change of ownership of the company took place in 2005, when Yinxing Zhiye entered the *ST Ice Bear, and then the listed company was renamed Oriental Yinxing. After the reorganization, Oriental Silver Star turned to the real estate industry, but after 2010, the real estate business of Oriental Silver Star came to a standstill.
In 2013, after four consecutive placards, Yushang Group gained 20% of the shares of Oriental Silver Star and became the second largest shareholder of the company.
The second change of control rights occurred in August 2015. Yinxing Zhiye transferred all the shares of Oriental Yinxing to Jinzhong Dongxin, and completely withdrew. However, during this period, Yushang Group continued to increase its holdings, and there was once a "double-headed board of directors" situation. In October 2016, Jinzhong Dongxin’s shareholding ratio rose to 32%, surpassing Yushang Group, which holds 31% of the shares.
In March 2017, the controlling share changed hands for the third time. Jinzhong Dongxin sold its 38,374,400 shares to Zhonggeng Group at a price of 56.03 yuan/share with a premium of 51%, with a total transfer price of 2.15 billion yuan.
With the entry of Zhonggeng Group, Oriental Silver Star began to cross the border frequently, but in the end it had little effect, only causing its share price to fluctuate greatly.
Oriental Silver Star’s main business was first transformed into a commodity supply chain management business with coal (including coke) as the main business, but the gross profit margin and profitability of this business were generally not high. In 2022, the gross profit margin of this business was only 1.34%.
In 2018, Oriental Silver Star planned to purchase 60% equity of Ningbo Zhongkairun in cash through a wholly-owned subsidiary, and then the target was changed to 51% equity of Qifan Investment, which is mainly engaged in investment in real estate-related fields and has invested in real estate projects in Fuzhou. But in the end, the acquisition fell through.
In 2021, Oriental Silver Star announced the cross-border semiconductor field, invested 30 million yuan to subscribe for the newly registered capital of Wuhan Minsheng, and held 2.91% equity of Wuhan Minsheng. Wuhan Minsheng is a MEMS manufacturer. In the end, the transformation did not have a big return.
On March 20, 2023, Oriental Silver Star changed its name to Geng Xing, and at the same time began a new transformation, announcing its entry into new energy business, mainly operating charging piles and charging stations. However, according to the company’s previously disclosed senior management resume and employee composition, the original team of Geng Xing shares lacked experience in the new energy industry.
According to the 2022 annual report, Geng Xing Co., Ltd. has only 37 employees, mainly sales, management and administration personnel, and zero production and technical personnel. According to the semi-annual report of Gengxing in 2023, its new energy vehicle charging business is still in the preparatory stage, and it has not officially opened for operation and generated business income.
Business is not good enough.
The frequent change of controlling rights and the transformation of main business have not brought actual returns to Geng Xing.
In 2021 and 2022, the revenue of Gengxing was 1.612 billion yuan and 1.848 billion yuan respectively, down 40.17% year-on-year and up 14.61%. The net profit was-42.75 million yuan and 16.94 million yuan respectively, down 287% and up 135% respectively.
In 2023, the company’s performance showed a "double decline". In the first three quarters of 2023, the company achieved revenue of 484 million yuan, down 70% year-on-year; The net loss was 32.37 million yuan, and the company’s performance turned from profit to loss.
Geng Xing shares had previously occupied funds by related parties. In 2022, due to the failure of affiliated companies to arrange payment and delivery settlement as agreed, nearly 170 million yuan of related funds were occupied. The 2022 annual report of Gengxing shares was issued with a qualified audit report by the audit institution.
Geng Xing shares said that from 2021 to 2022, the company was occupied by non-operating funds of Zhong Geng Group and its related parties. As of April 26, 2023, the controlling shareholder and its related parties have all returned the above-mentioned non-operating occupied funds and interest.
On January 15th, 2024, Geng Xing shares disclosed that it received the Notice of Filing a Case issued by China Securities Regulatory Commission on the same day. The CSRC decided to file a case against the company because the company was suspected of violating laws and regulations in information disclosure.
